ACE and ACE2 Activity in Diabetic MiceJan Wysocki, Daniel Batlle, Minghao Ye et al.|Diabetes|2006Cited by 339
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M. Apperloo, Hiddo J.L. Heerspink, Femke Waanders et al.|Nature Medicine|2024Cited by 95
A misprocessed form of Apolipoprotein A-I is specifically associated with recurrent Focal Segmental GlomerulosclerosisConxita Jacobs-Cachá, Joan López-Hellín, Natàlia Puig-Gay et al.|Scientific Reports|2020Cited by 18
Paraneoplastic Syndrome After Kidney Transplantation: Frequency, Risk Factors, Differences to Paraneoplastic Occurrence of Glomerulonephritis in the Native Kidney, and Implications on Long-Term Kidney Graft FunctionIzabela Zakrocka, Andreas Kronbichler, Gayatri Nair et al.|Transplant International|2024Cited by 2
Effects of Semaglutide on Kidney Parameters in Patients with Obesity and Nondiabetic CKDHiddo Jan L. Heerspink, José Luis Górriz, Ellen M. Apperloo et al.|Journal of the American Society of Nephrology|2024Cited by 0